| Gene Set | Leading Edge Genes |
|---|
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | TMPO, DNM1L, DBF4, NMD3, GINS2, STMN1, RAP2A /// RAP2B, SMC2, SFRS6, PSAT1, KCTD5, SHCBP1, GINS1, ABCD3, OSBPL3, STIL, UBE2W, DDX39, GSR, KIF14, CHEK1, C21ORF45, RASAL2, MAPK1, C1ORF103, EXOC5, ATAD2, INTS7, CEBPG, HELLS, ZWILCH, TMEM48, TFAM, SEPT10, AGPS, MCM4, KIF18A, CCNE2, TSN, SUV39H2, CYP51A1, DNAJC9, RAD51AP1, HAT1, YIPF5, PRKAA1, XRCC4, SMC4, USP1, CENPQ |
| KINSEY TARGETS OF EWSR1 FLII FUSION UP | PPP1R7, POLE3, TMPO, DBF4, PAK2, GINS2, DCP2, SMC2, PSAT1, SLBP, BAG5, RCOR1, GINS1, WRB, MSH2, ZNF93, FBXO28, KIF14, TFDP1, CHEK1, KCTD9, ASF1A, EXOC5, ATAD2, MBD4, PHF20L1, HELLS, ABHD3, CCNF, PPP2R2D, DNAJB1, SHMT1, AKAP12, PTPLAD1, BAG2, SEPT10, MCM4, EIF2B1, CCNE2, SFRS1, GTF2A2, TSN, SUV39H2, NET1, PRKAA1, ARMC1, SMC4, C12ORF29, NUDT4 /// NUDT4P1, RAD1 |
| ZHANG BREAST CANCER PROGENITORS UP | RNF6, SLC38A1, TMPO, HELLS, DBF4, STMN1, PSAT1, CHEK1, SHMT1, SHCBP1, USP1, SMC4, PCYOX1 |
| SHEN SMARCA2 TARGETS UP | MBD4, DCTN4, PRKAR1A, SOS2, IDS, RAB40B, FBXO3, BTBD3, PPP1R2, SEPT10, RBM16, SLC30A5, SOCS6, RMND5A, PPWD1, KIDINS220, PURA, FBXO28, TSN, RAB4A, USP1, TWSG1, SNX5, SMC5 |
| CAFFAREL RESPONSE TO THC DN | |
| TURASHVILI BREAST CARCINOMA DUCTAL VS LOBULAR UP | |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | ASF1A, ACTL6A, MBD4, C10ORF137, C17ORF42, ABHD3, DBF4, TMEM165, NCLN, C11ORF73, CHEK1, ZNF131, UPF3A, LRRC40, PPP2R5C |
| BORCZUK MALIGNANT MESOTHELIOMA UP | |
| BOYAULT LIVER CANCER SUBCLASS G123 UP | |
| DING LUNG CANCER EXPRESSION BY COPY NUMBER | |
| GEORGES TARGETS OF MIR192 AND MIR215 | |
| STEIN ESRRA TARGETS RESPONSIVE TO ESTROGEN DN | |